October 30, 2009 / 8:02 AM / 10 years ago

OncoTherapy Science <4564.T>-6mth group results

   Oct 30 (Reuters) -
                ONCOTHERAPY SCIENCE INC
                CONSOLIDATED FINANCIAL HIGHLIGHTS
 (in billions of yen unless specified)
            6 months ended  6 months ended  Full year to    Full year ended
               Sep 30, 2009    Sep 30, 2008    Mar 31, 2010    Mar 31, 2009
               LATEST          YEAR-AGO        COMPANY         YEAR-AGO  
               H1 RESULTS      H1 RESULTS      FORECAST        RESULTS   
 Sales               1.13             222 mln        4.45                   
               (+410.0 pct)                        (+33.7%)              
 Operating      loss 1.24       loss 1.29        prft 248 mln               
                                                  (+815.0%)              
 Recurring      loss 1.22       loss 1.27        prft 299 mln               
                                                  (+150.7%)              
 Net            loss 1.23       loss 1.28        prft 250 mln               
                                                   (+69.3%)              
 EPS           loss Y6,069.74  loss Y6,391.42  prft Y1,240.31               
 Annual div                                                nil             nil
  -Q4 div                                  nil             nil              
 NOTE - OncoTherapy Science Inc engages in R&D of cancer drugs.
 For latest earnings estimates made by Toyo Keizai, please
double click on 4564.TK1.

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below